Jabir Abdulakutty, Atul Abhyankar, Sandeep Seth, Kamal Sharma, Rakesh Kumar Aggarwal, Nirav Bhalani et al. Study Design and Baseline Characteristics of the VERINA Study: Phase IV Evidence of Vericiguat for Worsening Heart Failure Management. // Cardiology and Therapy. – 2025. – DOI: 10.1007/s40119-025-00442-4. – URL: https://doi.org/10.1007/s40119-025-00442-4
Jabir Abdulakutty, Atul Abhyankar, Sandeep Seth, Kamal Sharma, Rakesh Kumar Aggarwal, Nirav Bhalani, Vinod Vijan, Sandeep Bansal, Rajendra Kumar Premchand Jain, Suvro Banerjee, V. K. Chopra, Abraham Oomman, Pravin Kahale, Priyanka Sodhi, & Ashish Gawde (2025). Study Design and Baseline Characteristics of the VERINA Study: Phase IV Evidence of Vericiguat for Worsening Heart Failure Management. Cardiology and Therapy. https://doi.org/10.1007/s40119-025-00442-4
Jabir Abdulakutty, et al. “Study Design and Baseline Characteristics of the VERINA Study: Phase IV Evidence of Vericiguat for Worsening Heart Failure Management.” Cardiology and Therapy, 2025. doi:10.1007/s40119-025-00442-4.
@article{Abdulakutty2025,
title = {Study Design and Baseline Characteristics of the VERINA Study: Phase IV Evidence of Vericiguat for Worsening Heart Failure Management},
author = {Abdulakutty, Jabir and Abhyankar, Atul and Seth, Sandeep and Sharma, Kamal and Aggarwal, Rakesh Kumar and Bhalani, Nirav and Vijan, Vinod and Bansal, Sandeep and Jain, Rajendra Kumar Premchand and Banerjee, Suvro and Chopra, V. K. and Oomman, Abraham and Kahale, Pravin and Sodhi, Priyanka and Gawde, Ashish},
journal = {Cardiology and Therapy},
year = {2025},
doi = {10.1007/s40119-025-00442-4},
url = {https://doi.org/10.1007/s40119-025-00442-4}
}